Welcome to our dedicated page for KNOREX LTD. news (Ticker: KNRX), a resource for investors and traders seeking the latest updates and insights on KNOREX LTD. stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect KNOREX LTD.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of KNOREX LTD.'s position in the market.
Knorex (NYSE American: KNRX), an AI-driven digital advertising solutions provider, has successfully completed its Initial Public Offering (IPO) of 3,000,000 Class A ordinary shares at $4.00 per share, raising gross proceeds of $12.0 million before deductions.
The company began trading on the NYSE American on September 29, 2025, under the symbol "KNRX". The underwriters, led by R. F. Lafferty & Co. Inc., have a 45-day option to purchase up to 450,000 additional shares to cover over-allotments. The IPO was conducted on a firm commitment basis with Craft Capital Management LLC serving as co-manager.
FAQ
What is the current stock price of KNOREX LTD. (KNRX)?
What is the market cap of KNOREX LTD. (KNRX)?
